Zhi Chen

USPTO Granted Patents = 12 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 9.5

ph-index = 5

Forward Citations = 110(Granted Patents)

Location History:

West Haven, CT (US) (2005)
Hamden, CT (US) (2003 - 2011)
Lyndhurst, NJ (US) (2010 - 2012)

Company Filing History:

Bayer Pharmaceuticals Corporation

where one patent can have more than one assignee

Years Active: 2003-2012

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8207166 - Substituted pyrazolyl urea derivatives useful in the treatment of cancer (2012-06-26),

2. 8076488 - Bicyclic urea derivatives useful in the treatment of cancer and other disorders (2011-12-13),

3. 7838524 - Substituted pyrazolyl urea derivatives useful in the treatment of cancer (2010-11-23),

4. 7585888 - Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders (2009-09-08),

5. 7557129 - Cyanopyridine derivatives useful in the treatment of cancer and other disorders (2009-07-07),

6. 7384947 - Fused tricyclic heterocycles useful for treating hyper-proliferative disorders (2008-06-10),

7. 7351735 - Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders (2008-04-01),

8. 7144885 - Fused tricyclic heterocycles useful for treating hyper-proliferative disorders (2006-12-05),

9. 7091240 - Tubulin binding ligands and corresponding prodrug constructs (2006-08-15),

10. 7001926 - Tubulin binding agents and corresponding prodrug constructs (2006-02-21),

11. 6956054 - Compositions and methods for use in targeting vascular destruction (2005-10-18),

12. 6593374 - Tubulin binding ligands and corresponding prodrug constructs (2003-07-15),

Title: The Innovative Contributions of Zhi Chen

Introduction

Zhi Chen is a prominent inventor based in Hamden, CT, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made remarkable strides in developing compounds that target serious health conditions, particularly cancer.

Latest Patents

Among his latest patents, Zhi Chen has developed "Substituted pyrazolyl urea derivatives useful in the treatment of cancer." This invention relates to compounds of formula (I), pharmaceutical compositions that contain them, and methods for treating cancer using these compounds. Another notable patent is for "Bicyclic urea derivatives useful in the treatment of cancer and other disorders." This invention focuses on novel diaryl ureas, pharmaceutical compositions containing such compounds, and their use for treating hyper-proliferative and angiogenesis disorders, either as a sole agent or in combination with cytotoxic therapies.

Career Highlights

Zhi Chen has worked with reputable organizations such as Bayer Healthcare LLC and Baylor University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Wendy Lee and Jacques P Dumas, who have played a role in his innovative projects and research endeavors.

Conclusion

Zhi Chen's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in cancer treatment. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.